首页> 外文会议>The 3rd International Conference on Bioinformatics and Biomedical Engineering(iCBBE 2009)(第三届生物信息与生物医学工程国际会议)论文集 >Preparation and characterization of PLA ultrasound contrast agents by combining an ultrasound method and a Shirasu Porous Glass (SPG) membrane emulsification technique
【24h】

Preparation and characterization of PLA ultrasound contrast agents by combining an ultrasound method and a Shirasu Porous Glass (SPG) membrane emulsification technique

机译:超声法和白苏多孔玻璃膜乳化技术相结合制备和表征PLA超声造影剂

获取原文

摘要

The ultrasound contrast agent based on a poly lactic acid (PLA) was prepared by combining an ultrasound method and a Shirasu Porous Glass (SPG) membrane emulsification technique. An aqueous phase containing ammonium bicarbonate was used as the internal water phase (W1), and PLA and Span 80 were dissolved in a solvent of dichloromethane (DCM), which was used as the oil phase (O). These two solutions were probe sonicated to form a W1/O primary emulstion. The primary emulsion was permeated through the uniform pores (1.1 μm) of an SPG membrane into the external water phase (W2) by the pressure of nitrogen gas to form the uiniform W1/O/W2 droplets. After DCM was evaporated, the hardened PLA microcapsules were further formulated into a lyophilized powder containing decafluorobutane gas. SEM image demonstrated that the PLA microcapsules were sphere-shaped and internally hollow with an average diameter ranging from 1.99 to 3.58 μm. In vitro, the PLA contrast agents showed high acoustic enhancement properties, the enhancement increased nonlinearly with dose, and the minimal loss (less than 5 dB) of signal was observed over 20 min of analysis at 37 ℃, the maximum acoustic enhancement was 45 dB, which significantly higher (p<0.01) compared to a value of 28 dB for those prepared by a conventional solvent evaporation method. In conclusion, the hollow PLA microcapsules prepared by the novel method have the characteristics desirable for an intravenously administered ultrasound contrast agents.
机译:通过结合超声方法和Shirasu多孔玻璃(SPG)膜乳化技术,制备了基于聚乳酸(PLA)的超声造影剂。将包含碳酸氢铵的水相用作内部水相(W1),并将PLA和Span 80溶于二氯甲烷(DCM)的溶剂中,将其用作油相(O)。对这两种溶液进行探针超声处理以形成W1 / O初乳。在氮气的压力下,初级乳液通过SPG膜的均匀孔(1.1μm)渗透到外部水相(W2)中,形成Uini型W1 / O / W2液滴。在蒸发DCM之后,将硬化的PLA微胶囊进一步配制成含有十氟丁烷气体的冻干粉末。 SEM图像表明,PLA微囊为球形,内部为中空,平均直径为1.99至3.58μm。在体外,PLA造影剂显示出高声增强特性,增强剂量随剂量呈非线性增加,并且在37℃的分析条件下20分钟内观察到最小的信号损失(小于5 dB),最大声增强为45 dB与通过传统溶剂蒸发方法制备的28 dB值相比,该值显着更高(p <0.01)。总之,通过该新方法制备的中空PLA微胶囊具有静脉内施用的超声造影剂所需的特性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号